As adverse events , hyperglycemia and oral moniliasis were observed in the PS group ( n = @ ) and in the NB groups ( n = @ ) , respectively , and treatment change was required in @ patients ( @ patients in the PS group and @ patients in the NB groups ) ( p = @ ) .